Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke

Keywords

Minocycline, Neuroprotection, Matrix metalloproteinase, Ischemia, Pharmacology

References

• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and BiochemistryAngel de Lamorena — 2003
• Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection.Fernando Suárez González — 2004
• The Potential of Minocycline for Neuroprotection in Human Neurologic DiseaseD. Barber Hernández — 2004
• Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester.Roeland Hanemaaijer, Pieter Koolwijk, L le Clercq — 1993
• Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in ratsLin Xu, Susan C. Fagan, Jennifer L. Waller — 2004
• Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1Thorsten Sadowski, Jürgen Steinmeyer — 2001
• Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in RatGary A. Rosenberg, Milo Navratil, Frank C. Barone — 1996
• Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier DysfunctionYvan Gasche, Miki Fujimura, Yuiko Morita‐Fujimura — 1999
• The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.Liesbet Paemen, Erik Martens, Koen Norga — 1996
• Minocycline Protects against Permanent Cerebral Ischemia in Wild Type but Not in Matrix Metalloprotease-9-Deficient MiceMilla Koistinaho, Tarja Malm, Mikko I. Kettunen — 2005
• Neuroprotection by tetracyclines.Marı́a Domercq, Carlos Matute — 2004
• A Highly Specific Inhibitor of Matrix Metalloproteinase-9 Rescues Laminin from Proteolysis and Neurons from Apoptosis in Transient Focal Cerebral IschemiaZezong Gu, Jiankun Cui, Stephen H.M. Brown — 2005
• Cerebral Microvessel Responses to Focal IschemiaGregory J. del Zoppo, Takuma Mabuchi — 2003
• Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinasesEng H. Lo, Xiaoying Wang, M. L. Cuzner — 2002
• Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.Juha Yrjänheikki, Riitta Keinänen, M. Pellikka — 1998
• A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window.Juha Yrjänheikki, Tiina Tikka, Riitta Keinänen — 1999
• Metalloproteinases in biology and pathology of the nervous systemV. Wee Yong, Christopher Power, Peter Forsyth — 2001
• Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94Minoru Asahi, Kazuko Asahi, Jae‐Chang Jung — 2000
• Suppression of human neutrophil functions by tetracyclines.Walter L. Gabler, Howard R. Creamer — 1991
• Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral IschemiaJi Hoe Heo, Jacinta Lucero, Takeo Abumiya — 1999

Cited by

• Minocycline reduces oxygen–glucose deprivation-induced PC12 cell cytotoxicity via matrix metalloproteinase-9, integrin β1 and phosphorylated Akt modulationXiaohong Chen, Shaoqiong Chen, Ying Jiang — 2013
• Development and characterization of a Yucatan miniature biomedical pig permanent middle cerebral artery occlusion stroke model英昌 山口 — 2014
• Microglia–blood vessel interactions: a double-edged sword in brain pathologiesM.J. Van der Ploeg — 2016
• Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in StrokePat Cox — 2017
• Neural stem cell therapy for subacute and chronic ischemic strokeA. Cayol, G. Clottes, P. Loriot — 2018
• Osteopontin Expression During the Acute Immune Response Mediates Reactive Synaptogenesis and Adaptive OutcomeJulie L. Chan — 2013
• Protection of minocycline on early brain injury after subarachnoid hemorrhage in rats.Zongduo Guo, Haitao Wu, Xiaochuan Sun — 2011
• L'activation des α-sécrétases : une nouvelle stratégie thérapeutique pour le traitement du traumatisme crânienE. Siopi — 2012
• Sequential Therapy with Minocycline and Candesartan Improves Long Term Recovery after Experimental StrokeSahar Soliman, Tauheed Ishrat, Abdelrahman Y. Fouda — 2015
• Tratamento com minociclina e transplante intraestriatal de células mononucleares da medula óssea após acidente vascular experimental encefálicoMichelle Castro da Silva — 2011
• Oxygen-glucose deprivation (OGD) promotes microglia activation and gliogenesis but not neurogenesis in organotypic hippocampal slice culture (OHC)Małgorzata Ziemka‐Nałęcz, Luiza Stanaszek, H Zajac — 2013
• Effects of minocycline on apoptosis and angiogenesis-related protein expression in a rat model of intracerebral hemorrhageRuizhi Wang, Dongning Hao, Wei Shi — 2012
• The role of extracellular matrix and matrix-degrading proteases in neonatal hypoxic-ischemic injuryChristopher C. Leonardo — 2008
• Involvement of matrix metalloproteinases‐2 and ‐9 in the formation of a lacuna‐like cerebral cavityFrancisco S. Cayabyab, Krishnamoorty Gowribai, Wolfgang Walz — 2013
• Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury After Subarachnoid HemorrhageJianru Li, Jingsen Chen, Hangbo Mo — 2016
• Inflammation and neuroprotective strategies in the immature brain after hypoxic-ischemic brain injuryPernilla Svedin — 2008
• Metalloproteinase and stroke infarct size: role for anti‐inflammatory treatment?Anna Morancho, Anna Rosell, Lidia García‐Bonilla — 2010
• New prognostic biomarkers in patients with ischemic stroke.L. Lorente — 2015
• Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarctionLeonardo Lorente, María M. Martín, Luís Ramos — 2015
• The Role of Circulating Tight Junction Proteins in Evaluating Blood Brain Barrier Disruption following Intracranial HemorrhageXiaoyang Jiao, Ping He, Yazhen Li — 2015

Related papers

• Minocycline mechanism of neuroprotection involves the Bcl-2 gene family in optic nerve transectionHani Levkovitch-Verbin, Yael Waserzoog, Shelly Vander — 2014
• Minocycline for Short‐Term NeuroprotectionHazem Elewa, Hend Hilali, David C. Hess — 2006
• Additive neuroprotective effects of minocycline with creatine in a mouse model of ALSWen‐Hua Zhang, Malini Narayanan, Robert M. Friedlander — 2003
• Rise and fall of minocycline in neuroprotection: need to promote publication of negative results.Elsa Diguet, Christian E. Gross, François Tison — 2004
• Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic strokeNoriyuki Matsukawa, Takao Yasuhara, Koichi Hara — 2009
• Prospects for Minocycline NeuroprotectionJennifer M. Plane, Yan Shen, David Pleasure — 2010
• Neuroprotective effects of minocycline in ischemic strokeZhenguang Li, Xinghua Cui, Jinbiao Zhang — 2017
• Neuroprotection & Mechanism of Ethanol in Stroke and Traumatic Brain Injury Therapy: New Prospects for an Ancient DrugKaram Asmaro, Paul Fu, Yuchuan Ding — 2012
• Current status and challenges in neuroprotective agents for is chendc strokeXingyong Chen, Ruxun Huang — 2011